{"id":40149,"date":"2025-12-02T21:00:00","date_gmt":"2025-12-02T14:00:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=40149"},"modified":"2025-12-02T21:00:00","modified_gmt":"2025-12-02T14:00:00","slug":"neurophet-appoints-josh-cohen-former-executive-from-a-global-medical-ai-firm-as-head-of-americas-business-to-accelerate-u-s-market","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=40149","title":{"rendered":"Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business &#8212; To Accelerate U.S. Market"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1954882\/Neurophet_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li>Expert in sales and commercial strategy\u2026Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai<\/li>\n<li>To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SEOUL, South Korea<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Dec. 2, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on <span>2nd<\/span> that it has appointed <span class=\"xn-person\">Josh Cohen<\/span>, a veteran executive from leading global medical device companies, as new Head of Americas Business.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p> <a href=\"https:\/\/mma.prnasia.com\/media2\/2836097\/Josh_Cohen__Head_of_Americas_Business_at_Neurophet.html\" target=\"_blank\" rel=\"nofollow\"> <img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2836097\/Josh_Cohen__Head_of_Americas_Business_at_Neurophet.jpg?p=medium600\" title=\"Josh Cohen, Head of Americas Business at Neurophet\" alt=\"Josh Cohen, Head of Americas Business at Neurophet\" \/> <\/a> <br \/><span>Josh Cohen, Head of Americas Business at Neurophet<\/span><\/p>\n<\/div>\n<p><span class=\"xn-person\">Josh Cohen<\/span>, newly appointed Head of Americas, brings over a decade of expertise in sales and commercialization strategy within the medical AI sector. He has honed his skills through leadership roles in global sales and marketing at top-tier medical device companies, including Philips\u2014one of the world&#8217;s leading medical imaging manufacturers\u2014as well as Cortechs.ai, Shared Imaging, and most recently has worked as the acting Chief Commercial Officer (CCO) with MRI AI-based technology companies to launch and scale in the US and abroad.<\/p>\n<p><span class=\"xn-person\">Josh Cohen<\/span> previously served as CCO at Cortechs.ai, one of Neurophet&#8217;s global rivals, where he spearheaded the growth of key AI-driven brain imaging analysis products and led the company&#8217;s expansion across international markets. Cortechs.ai specializes in AI-based medical imaging analysis software and directly competes with Neurophet in the Americas region.<\/p>\n<p>Neurophet, market leader in the <span class=\"xn-location\">Asia Pacific<\/span> region, is now focused on accelerating its entry into the Americas with this key appointment. Having led the execution of global commercialization strategies at a leading AI brain imaging analysis company, <span class=\"xn-person\">Josh Cohen<\/span> will now build the team, the operations, and the customer success for Neurophet in the Americas.<\/p>\n<p>With patients, clinicians, and customer satisfaction at the forefront, Neurophet aims to drive revenue growth, establish distribution partnerships, and implement market entry strategies across <span class=\"xn-location\">Canada<\/span>, <span class=\"xn-location\">the United States<\/span>, and <span class=\"xn-location\">South America<\/span>.<\/p>\n<p><span class=\"xn-person\">Josh Cohen<\/span>, Head of Americas Business at Neurophet, stated &#8220;I am delighted to be part of Neurophet, a company with global competitiveness in the field of imaging analysis related to Alzheimer&#8217;s disease treatment prescriptions and look forward to accelerating product sales by strengthening our entry into the North American market.&#8221;<\/p>\n<p>Jake Junkil Been, Co-CEO of Neurophet, said\u00a0&#8220;With Josh Cohen joining us, the pivotal leader behind the rapid growth of our key competitor Cortechs.ai, Neurophet is well-positioned to accelerate product deployment throughout the North American market. Looking ahead, we aim to expand our product offerings with a strong focus on major healthcare institutions across <span class=\"xn-location\">the United States<\/span>.&#8221;<\/p>\n<p><b>About Neurophet<\/b><\/p>\n<p>Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.<\/p>\n<p>Major products include brain MRI analysis software &#8220;Neurophet AQUA&#8221;, PET Image Quantitative Analysis Software &#8220;Neurophet SCALE PET&#8221;, Brain imaging treatment planning software for electric and magnetic brain stimulation &#8220;Neurophet tES\/TMS LAB&#8221;, Alzheimer&#8217;s Disease treatment prescription and monitoring software &#8220;Neurophet AQUA AD&#8221; for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software &#8220;Neurophet AQUA MS&#8221;.<\/p>\n<p>Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain&#8217;s health and pioneer solutions for brain diseases with AI technology.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<\/div>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1954882\/Neurophet_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li>Expert in sales and commercial strategy\u2026Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai<\/li>\n<li>To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SEOUL, South Korea<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Dec. 2, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on <span>2nd<\/span> that it has appointed <span class=\"xn-person\">Josh Cohen<\/span>, a veteran executive from leading global medical device companies, as new Head of Americas Business.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p> <a href=\"https:\/\/mma.prnasia.com\/media2\/2836097\/Josh_Cohen__Head_of_Americas_Business_at_Neurophet.html\" target=\"_blank\" rel=\"nofollow\"> <img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2836097\/Josh_Cohen__Head_of_Americas_Business_at_Neurophet.jpg?p=medium600\" title=\"Josh Cohen, Head of Americas Business at Neurophet\" alt=\"Josh Cohen, Head of Americas Business at Neurophet\" \/> <\/a> <br \/><span>Josh Cohen, Head of Americas Business at Neurophet<\/span><\/p>\n<\/div>\n<p><span class=\"xn-person\">Josh Cohen<\/span>, newly appointed Head of Americas, brings over a decade of expertise in sales and commercialization strategy within the medical AI sector. He has honed his skills through leadership roles in global sales and marketing at top-tier medical device companies, including Philips\u2014one of the world&#8217;s leading medical imaging manufacturers\u2014as well as Cortechs.ai, Shared Imaging, and most recently has worked as the acting Chief Commercial Officer (CCO) with MRI AI-based technology companies to launch and scale in the US and abroad.<\/p>\n<p><span class=\"xn-person\">Josh Cohen<\/span> previously served as CCO at Cortechs.ai, one of Neurophet&#8217;s global rivals, where he spearheaded the growth of key AI-driven brain imaging analysis products and led the company&#8217;s expansion across international markets. Cortechs.ai specializes in AI-based medical imaging analysis software and directly competes with Neurophet in the Americas region.<\/p>\n<p>Neurophet, market leader in the <span class=\"xn-location\">Asia Pacific<\/span> region, is now focused on accelerating its entry into the Americas with this key appointment. Having led the execution of global commercialization strategies at a leading AI brain imaging analysis company, <span class=\"xn-person\">Josh Cohen<\/span> will now build the team, the operations, and the customer success for Neurophet in the Americas.<\/p>\n<p>With patients, clinicians, and customer satisfaction at the forefront, Neurophet aims to drive revenue growth, establish distribution partnerships, and implement market entry strategies across <span class=\"xn-location\">Canada<\/span>, <span class=\"xn-location\">the United States<\/span>, and <span class=\"xn-location\">South America<\/span>.<\/p>\n<p><span class=\"xn-person\">Josh Cohen<\/span>, Head of Americas Business at Neurophet, stated &#8220;I am delighted to be part of Neurophet, a company with global competitiveness in the field of imaging analysis related to Alzheimer&#8217;s disease treatment prescriptions and look forward to accelerating product sales by strengthening our entry into the North American market.&#8221;<\/p>\n<p>Jake Junkil Been, Co-CEO of Neurophet, said\u00a0&#8220;With Josh Cohen joining us, the pivotal leader behind the rapid growth of our key competitor Cortechs.ai, Neurophet is well-positioned to accelerate product deployment throughout the North American market. Looking ahead, we aim to expand our product offerings with a strong focus on major healthcare institutions across <span class=\"xn-location\">the United States<\/span>.&#8221;<\/p>\n<p><b>About Neurophet<\/b><\/p>\n<p>Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.<\/p>\n<p>Major products include brain MRI analysis software &#8220;Neurophet AQUA&#8221;, PET Image Quantitative Analysis Software &#8220;Neurophet SCALE PET&#8221;, Brain imaging treatment planning software for electric and magnetic brain stimulation &#8220;Neurophet tES\/TMS LAB&#8221;, Alzheimer&#8217;s Disease treatment prescription and monitoring software &#8220;Neurophet AQUA AD&#8221; for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software &#8220;Neurophet AQUA MS&#8221;.<\/p>\n<p>Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain&#8217;s health and pioneer solutions for brain diseases with AI technology.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<\/div>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-40149","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/40149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40149"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/40149\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}